Blood-brain barrier vs. focused ultrasound with MRI guidance

Researchers at the University of Virginia are exploring ways to break through the blood-brain barrier using MRI-guided focused ultrasound.

The neurological conditions for which they’re hoping to open new treatment pathways include brain tumors, stroke, epilepsy and Alzheimer’s disease, according to an item posted by UVA’s newsroom.

The piece presents insights into the work from biomedical engineer Richard Price, PhD, who says the combination of focused ultrasound with MRI guidance would allow treating clinicians to home in on, say, 5% of the brain.

The other 95%, “we don’t even touch. Then, when we apply the focused ultrasound, it opens the barrier there for a few hours.”

This would give clinicians plenty of time for precise administration of treatments like gene therapy, and the targeted brain section would close naturally, Price says.

“The blood-brain barrier is one of the greatest, if not the greatest, challenge to drug delivery for the central nervous system,” he adds. “Evolution gave us this barrier because the central nervous system needs to be protected. The problem is now we want to deliver something to those cells and evolution has had millions and millions of years to optimize a solution to stop it. I’m attempting to circumvent biology with physics.”

The research has run in several journals, according to UVA. To read the rest of the school’s news item, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup